PROV vs CBAN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

PROV

56.5
AI Score
VS
PROV Wins

CBAN

50.8
AI Score

Investment Advisor Scores

PROV

57score
Recommendation
HOLD

CBAN

51score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PROV CBAN Winner
Forward P/E 10.989 11.0011 PROV
PEG Ratio 4.0039 2.1066 CBAN
Revenue Growth -5.5% 26.0% CBAN
Earnings Growth 0.0% 50.2% CBAN
Tradestie Score 56.5/100 50.8/100 PROV
Profit Margin 16.4% 24.3% CBAN
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

PROV 1M: +0.0% · 3M: +0.5% CBAN 1M: +1.6% · 3M: -8.8%

Current Technical Phase

PROV

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope 0.2%) with fading momentum, RSI 40

RSI (14): 40.3 · Price: $18.10

CBAN

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -2.7%) with fading momentum, RSI 48

RSI (14): 48.4 · Price: $20.26

Fundamentals Snapshot

Metric PROV CBAN
Market Cap — —
Forward P/E 17.4 8.5
Trailing P/E 17.6 11.3
Revenue (TTM) — —
Revenue Growth -0.1% 0.3%
Gross Margin 1.0% 1.0%
Operating Margin 0.2% 0.3%
EPS 1.03 1.82
Dividend Yield 0.02% 0.02%

Frequently Asked Questions

Based on our detailed analysis, PROV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.